Heart Failure

"Heart Failure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Descriptor ID	D006333
MeSH Number(s)	C14.280.434
Concept/Terms	Heart Failure Heart Failure Cardiac Failure Heart Decompensation Heart Decompensation Decompensation, Heart Heart Failure, Right-Sided Heart Failure, Right-Sided Heart Failure, Right Sided Right-Sided Heart Failure Right Sided Heart Failure Myocardial Failure Myocardial Failure Congestive Heart Failure Congestive Heart Failure Heart Failure, Congestive Heart Failure, Left-Sided Heart Failure, Left-Sided Heart Failure, Left Sided Left-Sided Heart Failure Left Sided Heart Failure

Below are MeSH descriptors whose meaning is more general than "Heart Failure".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Heart Failure [C14.280.434]

Below are MeSH descriptors whose meaning is more specific than "Heart Failure".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heart Failure" by people in this website by year, and whether "Heart Failure" was a major or minor topic of these publications.

Bar chart showing 640 publications over 29 distinct years, with a maximum of 48 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	1	3
1998	1	1	2
2000	5	2	7
2001	4	1	5
2002	7	2	9
2003	7	2	9
2004	13	6	19
2005	14	3	17
2006	12	3	15
2007	11	4	15
2008	14	3	17
2009	10	10	20
2010	10	5	15
2011	23	5	28
2012	15	8	23
2013	31	5	36
2014	26	8	34
2015	23	8	31
2016	24	15	39
2017	26	4	30
2018	23	3	26
2019	28	6	34
2020	25	7	32
2021	24	6	30
2022	45	0	45
2023	48	0	48
2024	21	4	25
2025	14	2	16
2026	5	5	10

Below are the most recent publications written about "Heart Failure" by people in Profiles.

Leigh JW, Pressler SJ, Gerber BS, Kansal M, Cajita M, Kitsiou S. Tailored Text Messaging Intervention to Improve Self-Care in Patients With Heart Failure (Text4HF): Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2026 Jul 24; 15:e86667.

View in: PubMed
Schulz A, Maron MS, Peng LW, Maron BA, Amyar A, Ngo L, Olivotto I, Chan RH, Manning WJ, Rowin EJ, Nezafat R. Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2026 Jul 07; 15(13):e048066.

View in: PubMed
Chary AN, Tamma S, Bhananker AR, Ramirez J, Bozkurt B, Schoenfeld EM, Haimovich AD, Lam K, Naik AD. A qualitative study of goals of hospital care and health outcome goals among patients admitted for heart failure. Patient Educ Couns. 2026 Oct; 151:109769.

View in: PubMed
Fath AR, Aglan A, Naidu SS, Mader MJ, Chilton RJ, Elgendy IY, Maron MS, Rowin EJ. Mavacamten in Obstructive Hypertrophic Cardiomyopathy: National Insights on Access and Safety Profile From Real-World Data. J Am Heart Assoc. 2026 May 05; 15(9):e045994.

View in: PubMed
Qian F, Gajjar P, Prescott B, Mitchell GF, Xanthakis V, Rade JJ, Nayor M. Modifiable Correlates With Systemic Thromboxane Generation and Association With Cardiovascular Outcomes: Results From the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2026 Jun; 46(6):e324561.

View in: PubMed
Wilkie G, Takillapati S, Alhuarrat MAD, Whelan A, Rosenthal L, Kovell LC. Cardiac and Perinatal Outcomes Among Pregnancies With Maternal Cardiac Arrhythmias. Am J Cardiol. 2026 Jul 01; 270:17-21.

View in: PubMed
Jaiswal V, Mashkoor Y, Waqas M, Khan MS, Ahmed A, Deb N, Banach M, Dani SS, Zelniker TA, Alexander KM, Fonarow GC, Qamar A. All-cause and cause-specific mortality assessment in patients receiving sodium glucose co-transporter-2 inhibitors. Am J Med. 2026 Aug; 139(8):1032-1042.e19.

View in: PubMed
Maron BJ, Ommen SR, Nishimura RA, McKenna WJ, Rakowski H, Sherrid MV, Olivotto I, Braunwald E, Maron MS. Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies. J Am Heart Assoc. 2026 Jun 16; 15(12):e047462.

View in: PubMed
Ferrufino RA, Farroukh A, Gitundu S, Sepulvida D, Alcius A, Brovman E, Cobey F, Gebhardt BR. The Association of Pulmonary Artery to Aorta Diameter Ratio With Postoperative Outcomes Following Left Ventricular Assist Device Implantation. J Cardiothorac Vasc Anesth. 2026 Jun; 40(6):1696-1704.

View in: PubMed
Rosenthal DN, Amodeo A, Butterfield RJ, Butts R, Chrzanowski S, Cripe L, Day J, Davies R, Duong T, Evers P, Gambetta K, Harris R, Hayes E, Kaufman B, Lorts A, Mack G, Mackenzie SJ, Mammen P, Markham L, McAlister J, McDonald C, Nakano SJ, Nandi D, Navaratnam M, Nelson S, Parent JJ, Piccoli C, Richmond M, Rocha C, Sawnani H, Schrader R, Shell R, Shih R, Shugh S, Smart T, Soslow J, Spinner J, Taivassalo T, Tunugtla H, VanderPluym C, Veerapandiyan A, Villa C, Wittlieb-Weber C, Zafarullah M, Hollander S. Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era. Pediatr Transplant. 2026 01; 30(1):e70253.

View in: PubMed

People

Explore

Similar Concepts

Top Journals